The Program Project "Risk-Based Breast Cancer Screening in Community Settings" is a large undertaking involving three research projects, three cores, seven participating breast imaging registries, an advisory board, several governance committees, and various institutional and community partners. The program's success will require extensive coordination and communication among the various components. Core A, the Administrative Core, will be the operational backbone of this program, assisting all projects in achieving their objectives and collaborating with the other cores to ensure that the program functions efficiently and productively. This will include supporting logistic and financial requirements, developing effective communication strategies for collecting data and disseminating research findings, and creating mechanisms to encourage and facilitate data sharing with non-program investigators. The Administrative Core will also conduct an annual evaluation of the Program Project that assesses the performance and effectiveness of each research project and core, as well as examining the extent of collaboration, quality of communication, and scientific productivity across the entire program. The design of this core is based on our 16 years of experience working with the Breast Cancer Surveillance Consortium (BCSC) and its associated ancillary studies.
Its specific aims are to provide centralized support for the program, particularly in logistic and financial requirements;assist project and core leaders in communication, especially disseminating research findings internally and externally;facilitating collaboration with non-program investigators by maintaining and refining mechanisms to support sharing program data;and evaluating and improving program performance through annual evaluations.
The Administrative Core will provide operational structure to the program, providing overall administrative support, fiscal oversight, and administrative assistance to all projects and cores. The core will plan program meetings, generate progress reports for the National Cancer Institute (NCI), and oversee budgets. It will standardize and facilitate communication, provide leadership on confidentiality issues, coordinate dissemination of research findings, and evaluate program progress.
|Mandelblatt, Jeanne S; Stout, Natasha K; Schechter, Clyde B et al. (2016) Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med 164:215-25|
|Hubbard, Rebecca A; O'Meara, Ellen S; Henderson, Louise M et al. (2016) Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med 89:169-77|
|Kerlikowske, Karla; Vachon, Celine M (2016) Breast Density: More Than Meets the Eye. J Natl Cancer Inst 108:|
|Nyante, Sarah J; Lee, Sheila S; Benefield, Thad S et al. (2016) The association between mammographic calcifications and breast cancer prognostic factors in a population-based registry cohort. Cancer :|
|Houssami, Nehmat; Miglioretti, Diana L (2016) Digital Breast Tomosynthesis: A Brave New World of Mammography Screening. JAMA Oncol 2:725-7|
|Lee, Christoph I; Bogart, Andy; Germino, Jessica C et al. (2016) Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations. J Med Screen 23:24-30|
|Goodrich, Martha E; Weiss, Julie; Onega, Tracy et al. (2016) The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women. Breast J 22:616-622|
|Trentham-Dietz, Amy; Kerlikowske, Karla; Stout, Natasha K et al. (2016) Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Ann Intern Med 165:700-712|
|Nichols, Hazel B; Bowles, Erin J A; Islam, Jessica et al. (2016) Tamoxifen Initiation After Ductal Carcinoma In Situ. Oncologist 21:134-40|
|Durham, Danielle D; Robinson, Whitney R; Lee, Sheila S et al. (2016) Insurance-Based Differences in Time to Diagnostic Follow-up after Positive Screening Mammography. Cancer Epidemiol Biomarkers Prev 25:1474-1482|
Showing the most recent 10 out of 120 publications